Committed to Improving the Lives of Patients Worldwide
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide.
Celgene Inc., a wholly-owned subsidiary of Celgene Corp., established its presence in Canada in 2006 and is located in Mississauga, Ontario.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer.